Abstract
Who are the major players in testing for the number two killer in the world?
What revenues can companies competing in this market expect in the next five
years? How will the impact of trends such as an increased role of
pharmacodiagnostics, the use of multiplex assays and a new emphasis on service
products influence cancer diagnostics? These questions and more are answered
in Kalorama Information' s Worldwide Market for Cancer Diagnostics, 3rd
Edition. Diagnostic tests for effective cancer screening are obviously needed
more than ever. As cancer becomes more treatable, diagnostics are finding
multiple expanded roles, including pharmacodiagnostics for matching the
targeted treatment to the patient and ongoing disease monitoring as treatable
cancer enters the realm of the chronic disease. Kalorama Information' s
Worldwide Market for Cancer Diagnostics, 3rd Edition represents the third time
Kalorama has engaged in an exhaustive study on the status of this important
diagnostic market.
This report includes detailed market analysis of the following screening tests:
- DR-70
- HAAH
- ECPKA
- The Cancer Profile
As well as these specific cancer-screening tests:
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colon Cancer
- Lung Cancer
- Ovarian Cancer
- Prostate Cancer
This latest edition of Kalorama' s study takes a fresh look at all of these
developments both qualitatively and quanititatively. The report provides
revenue and growth forecasts through 2012 and, as in the previous edition,
analyzes the market in two ways:
- Tests for specific cancers, and
- Cancer tests in specific IVD segments
This allows the reader to match his or her own situation to the market at
large.
In addition to extensive reviews of products on the market and in development
in each segment, the report also provides the most extensive review of
innovative companies yet compiled in this market with profiles of over 150
companies active in the segment.
Kalorama' s diagnostics industry analyst Shara Rosen provides the rigorous
analysis and thoughtful research that has been made her market reports the
backbone of diagnostic market decision-making for years.
| 
View Cart
